GPR119 Polyclonal Antibody

GPR119 encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The G protein-coupled receptor 119 is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes.

The GPR119 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of GPR119 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards GPR119.

The GPR119 Polyclonal Antibody has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits exceptional sensitivity and minimal cross-reactivity, enabling accurate and reliable detection of GPR119 protein in complex biological matrices.

This antibody is manufactured under stringent quality control measures to ensure batch-to-batch consistency and reproducibility. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation steps. The GPR119 Polyclonal Antibody is compatible with a wide range of experimental conditions and can be used in both research and clinical settings.

With its exceptional performance and reliability, the GPR119 Polyclonal Antibody is an indispensable tool for researchers and scientists studying GPR119 protein function and its role in various physiological and pathological processes.